Stabilization of selenite in a nutritional solution by dissolved oxygen
AssigneesBaxter International Inc., Baxter Healthcare S.A.
InventorsCaroline Dupont, Zouaoui Bourezg
Life of this patent
Estimating the term…
Abstract
The invention relates to a medical product for preventing or correcting selenium deficiency in a patient comprising a solution provided in a flexible container comprising at least one selenium compound in the form of Se(IV), which is preferably selected from the group consisting of sodium selenite, selenous acid and selenium dioxide, characterized in that the solution comprises dissolved oxygen (DO), preferably 0.5 ppm to 8 ppm DO.
Claims20
A medical product for preventing or correcting selenium deficiency in a patient, the medical product comprising an oxygen impermeable flexible container and further comprising a solution provided in the oxygen impermeable flexible container, wherein the solution comprises at least one selenium compound in the form of Se(IV) selected from the group consisting of sodium selenite, selenous acid and selenium dioxide, and wherein the solution comprises dissolved oxygen (DO) in a concentration from 0.5 ppm to 8 ppm.
A sterilized solution for parenteral administration comprising at least one selenium compound in the form of Se(IV) selected from the group consisting of sodium selenite, selenous acid and selenium dioxide, wherein the sterilized solution is formulated to prevent or correct selenium deficiency in a patient, wherein the solution comprises dissolved oxygen (DO), and wherein the sterilized solution is contained in an oxygen impermeable flexible container.
Dependencies are inferred from the claim text.